MedTrace Logo

Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates

NCT00203775 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-10-13

No results posted yet for this study

Summary

This study examines the efficacy of haldol versus risperdal in the treatment of aggression in psychotic prison inmates. It is hypothsized that risperdal will be more effective in decreasing aggression than haldol.

Conditions

Interventions

DRUG

risperidone

Sponsors & Collaborators

  • Janssen Pharmaceutica N.V., Belgium

    collaborator INDUSTRY

  • University of Connecticut

    lead OTHER

Principal Investigators

  • catherine f lewis, md · UConn Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-07-31
Completion
2004-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00203775 on ClinicalTrials.gov